Peer-influenced content. Sources you trust. No registration required. This is HCN.

Essential Medical Reading

Your Weekly Roundup of the Most-Read News and Clinical References from Your Peers

Clinical Advances in Hematology & Oncology

Advances in the Classification and Management of Patients with T-Cell Lymphoma

Hematology October 24th 2022

JAMA Network

Factors Associated with Patients Not Receiving Oral Anticancer Drugs

Medical Oncology October 24th 2022

Journal of Clinical Oncology

Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984

Medical Oncology October 24th 2022

Journal of Clinical Oncology

FORT-1: Phase II/III Study of Rogaratinib vs. Chemotherapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression

Hematology October 24th 2022

Blood

Lenalidomide Promotes the Development of TP53-Mutated Therapy-Related Myeloid Neoplasms

Hematology October 24th 2022

Blood Advances

Role of Stem Cell Transplant in CD30+ PTCL Following Frontline Brentuximab Vedotin Plus CHP or CHOP in ECHELON-2

Hematology October 24th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form